Adrenal suppression in the treatment of carcinoma of the prostate.
D000135:Acid Phosphatase / Q000097:blood; D000284:Administration, Oral; D000311:Adrenal Glands / Q000187:drug effects*; D000368:Aged; D000469:Alkaline Phosphatase / Q000097:blood; D000616:Aminoglutethimide / Q000008:administration & dosage / Q000494:pharmacology / Q000627:therapeutic use; D001706:Biopsy; D001859:Bone Neoplasms / Q000175:diagnosis; D001842:Bone and Bones / Q000000981:diagnostic imaging; D003348:Cortisone / Q000627:therapeutic use; D004054:Diethylstilbestrol / Q000008:administration & dosage / Q000494:pharmacology / Q000627:therapeutic use; D004359:Drug Therapy, Combination; D004967:Estrogens / Q000627:therapeutic use; D005438:Fludrocortisone / Q000627:therapeutic use; D006801:Humans; D008297:Male; D008875:Middle Aged; D009362:Neoplasm Metastasis; D011471:Prostatic Neoplasms / Q000188:drug therapy*; D014567:Urography
D004967:Estrogens; D000616:Aminoglutethimide; D004054:Diethylstilbestrol; D000469:Alkaline Phosphatase; D000135:Acid Phosphatase; D005438:Fludrocortisone; D003348:Cortisone